FDA ESTAR OVERVIEW

Currently, all medical device submissions for 510(k), De Novo, and Pre-Submissions may voluntarily use eSTAR. The intention of the program is to enhance the quality of submissions by providing a standardized format so submitters can ensure submissions are complete.  Additionally, the review process can be streamlined and more efficient.  Starting October 1, 2023, all 510(k) […]